This is a mobile optimized page that loads fast, if you want to load the real page, click this text.
Joined
27 June 2010
Posts
4,202
Reactions
328
Tyrian Diagnostics Limited (TDX), formerly Proteome Systems Limited (PXL), is an Australian-based company which develops and commercialises rapid point-of-need diagnostics for clinical and non-clinical applications.

http://www.tyriandiagnostics.com
 
On September 8th, 2016, Tyrian Diagnostics Limited (TDX) changed its name and ASX code to Contango Asset Management Limited (CGA).
 
LOL! Thats like my 55 $SGH shares, cost me $626 each adjusted for consolidation, now worth $2.16 per share for a total of $118.80
 
Reactions: Ann
This is a stock I would suggest everyone avoid like the plague, you run an excellent chance of losing all your money through a future stock Consolidation. It is a Rotting Souls stock.
 
All the while these wombats are pocketing errr 'management fees'. I heard one of the wombats (the mumbling one) say Contango Asset Management are a "very good fund manager".
 
Also note the smooth way they lull people into entrusting money with them. A class line up of experienced market investors. Pffft, diversify the funds over 40 or so companies, distribute the dividends to the blind faithfuls and pocket their management fee of 0.9 %. Money for jam and a clever way to keep money churning through the financial system.
 
I wonder if the gumby investors are being directed to that fund? Like a school of sharks working together to herd the gumby investors.
 
some flattering words about this mob.

Switzer Financial Group owns 13 per cent of Contango Asset Management, which in turn owns Switzer Asset Management. Contango is run by Peter’s devoted son Marty Switzer, ....
But, between April and September of 2020, "Contango applied for and received $292,500 in JobKeeper".

and some dubious connections
 
On November 18th, 2022, Contango Asset Management Limited (CGA) changed its name and ASX code to Associate Global Partners Limited (APL).
 
the Contango name has gone, but the job still seems to be distribution of funds through platforms and networks, originally for a US based manager
  • WCM Global Growth Limited (ASX:WQG) - $258m
  • WCM Quality Global Growth Fund (Quoted Managed Fund) (ASX:WCMQ) - $285m
  • WCM Quality Global Growth Fund (Managed Fund) - $164m
  • WCM International Small Cap Growth Fund (Managed Fund) - $87m
  • WCM Global Long Short Limited (ASX:WLS) - $23m
plus some Switzer cash and Yield funds, and a new distribution arrangement with Woodbridge Capital Pty Ltd, a new Australian domiciled private credit investment manager.

Rebrand to Become Associate Global Partners
• Operating under a single identity that aligns both the listed company and the responsible entity will provide clarity for clients and investors, enable the business to focus on its core objective of promoting its investment managers and position the Group for future growth
• The Group’s successful transition from being a manufacturer of financial products to a distributor has included:
• Partnering with WCM to grow FUM to over $817m1 since June 2017
• Outsourcing investment management to managers such as Coolabah and Blackmore
• Investing in its distribution capability to grow existing products organically in the advised and self-directed markets
• Launching products and offers that capture investor interest, including Woodbridge and Vantage

• The proposed new name better reflects the Group’s business model and strategic priorities and will not affect the names of any of its existing products or strategies

(not for me)
(code APL .... hinting at Approved Product List - geddit )
 
Cookies are required to use this site. You must accept them to continue using the site. Learn more...